News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Press releases

2014

10 September, 2014 PledPharma awarded Nordic Star of the Year News English IR Optional
28 August, 2014 PledPharma AB - Interim report second quarter 2014 News English Report Interim Q2 IR Optional
13 May, 2014 Rights issue in PledPharma oversubscribed News English IR Optional
25 April, 2014 PledPharma AB (publ) Interim report first quarter 2014 News English Report Interim Q1 IR Optional
24 March, 2014 PledPharma AB (publ) issues new shares News English IR Optional
19 February, 2014 Year end report 2013 News English Report Interim Yearend IR Optional
12 February, 2014 Positive data from the first part of the PLIANT study News English IR Optional

2013

10 December, 2013 First patient treated in part 2 of the PLIANT-study News English IR Optional
13 November, 2013 Go-ahead for PledPharma to start part 2 of the PLIANT study News English IR Optional
25 October, 2013 Interim Report Third Quarter 2013 News English Report Interim Q3 IR Optional
29 August, 2013 Interim Report Second Quarter 2013 News English Report Interim Q2 IR Optional
24 May, 2013 Rights issue in PledPharma oversubscribed News English IR Optional
18 April, 2013 Interim Report First Quarter 2013 News English Report Interim Q1 IR Optional
3 April, 2013 PledPharma AB (publ) issues new shares News English IR Optional

Calendar and upcoming reports

August 22, 2024
Interim Report Q2 2024 (7:00am CEST)

September 19, 2024
Pareto Annual Healthcare Conference

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com